Tag: Monoclonal Gammopathy

Acute Neurological Worsening After Rituximab Treatment in Patients with Anti-MAG Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Sala E et al.; Acute neurological worsening after Rituximab treatment in patients with anti-MAG neuropathy. J Neurol Sci. 2014 Oct 15; 345(1-2):224-7. PMID:25115501 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only. Not for use in diagnostic procedures in the US. Health Canada License: 89118

Prevalence, Specificity and Functionality of Anti-Ganglioside Antibodies in Neuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Prevalence, specificity and functionality of anti-ganglioside antibodies in Neuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol. 2014 Mar 15; 268(1-2): 89-94. PMID:24529728 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only. Not for use in diagnostic procedures in the US. Health Canada License: 89118

BÜHLMANN Laboratories AG (BL), based in Basel Switzerland, has been discovering, developing & manufacturing innovative chemistry and immunological in-vitro diagnostic (IVD) and research use only (RUO) assays for almost 50 years (circa 1976). As the United States commercial affiliate of BL, BUHLMANN Diagnostics Corp (BDC), based in Amherst, NH is committed to providing exceptional sales, support, and technical services to our clinical, discovery and basic science research laboratory customers.

Tag: Monoclonal Gammopathy

Acute Neurological Worsening After Rituximab Treatment in Patients with Anti-MAG Neuropathy

Prevalence, Specificity and Functionality of Anti-Ganglioside Antibodies in Neuropathy Associated with IgM Monoclonal Gammopathy

ABOUT US

SOCIAL MEDIA

QUICK LINKS

CONTACT US